Virus-like particles (VLPs) consist of one or more viral coat proteins that assemble into particles. They can be taken up by antigen presenting cells (APC), peptides derived from them are presented on MHC class I molecules at the cell surface, and thereby prime a CD8+ T cell response, either against the particle-forming protein itself (such as Hepatitis B surface antigen) or additional peptide sequences that are produced as fusions with the particle-forming protein. This article describes the...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Virus-like particles as vaccine adjuvants.
If you are the owner of this record, you can report an update to it here: Report update to this record